JP Morgan Maintains Overweight on CVS Health, Raises Price Target to $118

Benzinga Newsdesk www.benzinga.com Positive 74.7%

Neg 0% Neu 0% Pos 74.7%

JP Morgan analyst Lisa Gill maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $111 to $118.